Skip to content

EBITDA margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
27.2%-2.2pp
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
4.8%-18.4pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,940.4%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-3,925.4%-1,495pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-74.8%-37.3pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-1,759.7%+1,470pp

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$24.2M+10.7%
Net income-$19.9M+17.5%
EPS (diluted)-$0.42+38.2%

Balance sheet

See full
Cash & equivalents$78.1M+35.5%
Total debt$10.8M+37.8%
Total equity$471.5M+65.0%
Total assets$497.6M+64.7%

Cash flow

See full
Operating cash flow-$13.1M+35.5%
CapEx$86.0K-70.4%
Free cash flow-$13.1M+36.0%

Valuation

See full
Market cap$1.91B+309%

Returns & leverage

See full
Return on equity-28.3%
Debt / equity0.0×
Current ratio27.1×-3.9×